These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 28904175)
1. Splice variants of cytosolic polyadenylation element-binding protein 2 (CPEB2) differentially regulate pathways linked to cancer metastasis. DeLigio JT; Lin G; Chalfant CE; Park MA J Biol Chem; 2017 Oct; 292(43):17909-17918. PubMed ID: 28904175 [TBL] [Abstract][Full Text] [Related]
2. The Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2 Drives Anoikis Resistance and the Metastasis of Triple Negative Breast Cancer. Johnson RM; Vu NT; Griffin BP; Gentry AE; Archer KJ; Chalfant CE; Park MA J Biol Chem; 2015 Oct; 290(42):25717-27. PubMed ID: 26304115 [TBL] [Abstract][Full Text] [Related]
3. Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2. DeLigio JT; Stevens SC; Nazario-Muñoz GS; MacKnight HP; Doe KK; Chalfant CE; Park MA Mol Cancer Res; 2019 Sep; 17(9):1920-1930. PubMed ID: 31138601 [TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells. Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986 [TBL] [Abstract][Full Text] [Related]
5. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer. Chen D; Dang BL; Huang JZ; Chen M; Wu D; Xu ML; Li R; Yan GR Oncotarget; 2015 Oct; 6(32):32701-12. PubMed ID: 26196741 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression. Cho KH; Yu SL; Cho DY; Park CG; Lee HY BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789 [TBL] [Abstract][Full Text] [Related]
7. TP53I11 suppresses epithelial-mesenchymal transition and metastasis of breast cancer cells. Xiao T; Xu Z; Zhang H; Geng J; Qiao Y; Liang Y; Yu Y; Dong Q; Suo G BMB Rep; 2019 Jun; 52(6):379-384. PubMed ID: 30940320 [TBL] [Abstract][Full Text] [Related]
8. Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression. Nairismägi ML; Vislovukh A; Meng Q; Kratassiouk G; Beldiman C; Petretich M; Groisman R; Füchtbauer EM; Harel-Bellan A; Groisman I Oncogene; 2012 Nov; 31(47):4960-6. PubMed ID: 22266852 [TBL] [Abstract][Full Text] [Related]
9. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3. Chen SY; Teng SC; Cheng TH; Wu KJ Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472 [TBL] [Abstract][Full Text] [Related]
10. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion. Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707 [TBL] [Abstract][Full Text] [Related]
11. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition. Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736 [TBL] [Abstract][Full Text] [Related]
12. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression. Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420 [TBL] [Abstract][Full Text] [Related]
13. Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition. Li S; Zhang J; Yang H; Wu C; Dang X; Liu Y Sci Rep; 2015 Jul; 5():12410. PubMed ID: 26174737 [TBL] [Abstract][Full Text] [Related]
14. Thrombin induces expression of twist and cell motility via the hypoxia-inducible factor-1α translational pathway in colorectal cancer cells. Chang LH; Chen CH; Huang DY; Pai HC; Pan SL; Teng CM J Cell Physiol; 2011 Apr; 226(4):1060-8. PubMed ID: 20857420 [TBL] [Abstract][Full Text] [Related]
15. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation. Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682 [TBL] [Abstract][Full Text] [Related]
16. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207 [TBL] [Abstract][Full Text] [Related]
17. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein. Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325 [TBL] [Abstract][Full Text] [Related]
18. Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation. Ma G; He J; Yu Y; Xu Y; Yu X; Martinez J; Lonard DM; Xu J Int J Biol Sci; 2015; 11(5):618-28. PubMed ID: 25892968 [TBL] [Abstract][Full Text] [Related]
19. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1. Pei XH; Lv XQ; Li HX Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904 [TBL] [Abstract][Full Text] [Related]
20. Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Li QQ; Xu JD; Wang WJ; Cao XX; Chen Q; Tang F; Chen ZQ; Liu XP; Xu ZD Clin Cancer Res; 2009 Apr; 15(8):2657-65. PubMed ID: 19336515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]